Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars

Clinical Science

Volumn 90, Issue 5, 1996, Pages 417-425

  Scott, P G ^a   Dodd, C M ^a   Tredget, E E ^a   Ghahary, A ^a   Rahemtulla, F ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Burns; Dermatan sulphate; Proteoglycans; Wound healing

Indexed keywords

BIGLYCAN; CHONDROITIN 6 SULFATE; DECORIN; GUANIDINE; HYDROXYPROLINE; PROTEOGLYCAN; URONIC ACID; WATER;

AMINO ACID COMPOSITION; ARTICLE; BURN; BURN SCAR; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; ION EXCHANGE CHROMATOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0029988425     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900417     Document Type: Article

References (54)

1. 1, type I and type III procollagen in post-burn hypertrophic scar tissues. J Clin Lab Med 1993; 122: 465-73.
2. Linares HA, Kischer CW, Dobrkovsky K, Larson DL. The histiotypic organization of the hypertrophic scar in humans. J. Invest Dermatol 1972; 59: 323-31.
3. Shetlar MR, Dobrkovsky M, Linares L, Villarante R, Shetlar CL, Larson DL. The hypertrophic scar. Glycoprotein and collagen components of burn scars. Proc Soc Exp Biol Med 1971; 138: 298-300.
4. Ogston AC. In: Balazs EA, ed. Chemistry and molecular biology of the intercellular matrix. New York: Academic Press, 1970: vol. 3, 1231-40.
5. Scott JE. Proteoglycan-fibrillar collagen interactions. Biochem J 1988; 252: 313-23.
6. Chopra RK, Pearson CH, Pringle GA, Fackre DS, Scott PG. Dermatan sulphate is located on serine-4 of bovine skin proteodermatan sulphate. Biochem J 1985; 232: 277-9.
7. Krusius T, Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA 1986; 83: 7683-7.
8. Scott PG, Dodd CM. The N-linked oligosaccharides of bovine skin proteodermatan sulphate. Biochem Soc Trans 1989; 17: 1031-2.
9. Scott JE, Orford CR, Hughes EW. Proteoglycan-collagen arrangements in developing rat tail tendon. Biochem J 1981; 195: 573-81.
10. Scott JE. Proteoglycan-fibrillar collagen interactions in tissues: dermatan sulphate proteoglycan as a tissue organizer. In: Scott JE, ed. Dermatan sulphate proteoglycans: chemistry, biology, chemical pathology. London: Portland Press, 1993: 165-81.
11. Scott JE, Haigh M. Proteoglycan-type I collagen fibril interactions in calcifying and non-calcifying connective tissues. Biosci Rep 1985; 5: 71-81.
12. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature (London) 1990; 346: 282-4.
13. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
14. Takeuchi Y, Kodama Y, Matsumoto T. Bone matrix decorin binds transforming growth factor β and enhances its bioactivity. J Biol Chem 1994; 269: 32634-8.
15. Swann DA, Garg HG, Hendry CJ, et al. Isolation and partial characterization of dermatan sulfate proteoglycans from human post-burn scar tissues. Collagen Relat Res 1988; 8: 295-313
16. Neame PJ, Choi HU, Rosenberg LC. The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage. J Biol Chem 1989; 264: 8653-61.
17. Heinegård D, Sommarin Y. Proteoglycans: an overview. Methods Enzymol 1989; 144: 305-19.
18. Schönherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H. Interaction of biglycan with type I collagen. J Biol Chem 1995; 270: 2776-83.
19. Zimmerman DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 1989; 8: 2975-81.
20. Kahari V-M, Larjava H, Uitto J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. J Biol Chem 1991; 266: 10608-15.
21. Shetlar MR, Shetlar CL, Linares HA. The hypertrophic scar: location of glycosaminoglycans within scars. Burns 1977; 4: 14-19.
22. Alexander SA, Donoff RB. The histochemistry of glycosaminoglycans within hypertrophic scars. J Surg Res 1980; 28: 171-81.
23. Swann DA, Garg HG, Jung W, Hermann H. Studies in human scar tissue proteoglycans. J Invest Dermatol 1985; 84: 527-31.
24. Garg HG, Siebert EP, Swann DA. Isolation and some structure analyses of a copolymeric chondroitin sulfate-dermatan sulfate proteoglycan from post-burn, human hypertrophic scar. Carbohydr Res 1990; 197: 159-69.
25. Garg HG, Lippay EW, Burd AR. Purification and characterization of iduronic acid-rich and glucuronic acid-rich proteoglycans implicated in human post-burn keloid scar. Carbohydr Res 1990; 207: 295-305.
26. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982; 9: 247-8.
27. Scott PG, Nakano T, Dodd CM, Pringle GA, Kuc IM. Proteoglycans of the articular disc of the bovine temporomandibular joint. II. Low molecular weight dermatan sulphate proteoglycan. Matrix 1989; 9: 284-92.
28. Pringle GA, Dodd CM, Osborn JW, Pearson CH, Mosmann TR. Production and characterization of monoclonal antibodies to bovine skin proteodermatan sulfate. Collagen Relat Res 1985; 5: 23-39.
29. Scott PG, Dodd CM, Pringle GA. Mapping the locations of the epitopes of five monoclonal antibodies to the core protein of dermatan sulfate proteoglycan II (decorin). J Biol Chem 1993; 268: 11558-64.
30. Larjava H, Häkkinen L, Rahemtulla F. A biochemical analysis of human periodontal tissue proteoglycans. Biochem J 1992; 284: 267-74.
31. Scott PG, Dodd CM, Tredget EE, Ghahary A, Rahemtulla F. Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-β in human post-burn hypertrophic and mature scars. Histopathology 1995; 26: 423-31.
32. Avnur Z, Geiger B. Immunocytochemical localization of native chondroitin-sulface in tissues and cultured cells using specific monoclonal antibody. Cell 1984; 38: 811-22.
33. Stegemann H, Stalder K. Determination of hydroxyproline. Clinica Chim Acta 1967; 18: 267-73.
34. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem 1962; 4: 330-4.
35. Scott JE. Aliphatic ammonium salts in the assay of acidic polysaccharides from tissues. Methods Biochem Anal 1960; 8: 145-97.
36. Glossl J, Beck M, Kresse H. Biosynthesis of proteodermatan sulfate in cultured human fibroblasts. J Biol Chem 1984; 259: 14144-50.
37. Scott PG, Nakano T, Dodd CM. Small proteoglycans from different regions of the fibrocartilaginous temporomandibular joint disc. Biochim Biophys Acta 1995; 1244: 121-8.
38. Garg HG, Burd AR, Swann DA. Small dermatan sulphate proteoglycans in human epidermis and dermis. Biomed Res 1989; 10: 197-207.
39. Nakano T, Scott PG. Partial purification and characterization of proteodermatan sulphate-degrading proteinases produced by human gingival fibroblasts. Biomed Res 1988; 9: 269-79.
40. Franzén A, Heinegård D. Characterization of proteoglycans from the calcified matrix of bovine bone. Biochem J 1984; 224: 59-66.
41. Choi HU, Johnson TL, Pal S, Tang LH, Rosenberg L, Neame PJ. Characterization of the dermatan sufate proteoglycans DS-PGI and DS-PGII from bovine articular cartilage and skin isolated by octyl-Sepharose chromatography. J Biol Chem 1989; 264: 2876-84.
42. Zimmerman DR, Dours-Zimmerman NT, Schubert M, Bruckner-Tuderman L. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol 1994; 124: 817-25.
43. Evanko SP, Vogel KG. Ultrastructure and proteoglycan composition in the developing fibrocartilaginous region of bovine tendon. Matrix 1990; 10: 420-36.
44. Kuc IM, Scott PG. Ultrastructure of the bovine temporomandibular joint disc. Arch Oral Biol 1994; 39: 57-61.
45. Bianco P, Fisher LW, Young MF, Termine JG, Robey PG. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 1990; 38: 1549-63.
46. Brown DC, Vogel KG. Characteristics of the in vitro interaction of a small proteoglycan (PG II) at bovine tendon with type I collagen. Matrix 1989; 9: 468-78.
47. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor-β with hepatic fibrosis. J Cell Biol 1989; 108: 2477-82.
48. Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989; 170: 727-37.
49. 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990; 86: 917-22.
50. 1 mRNA. J Invest Dermatol 1991; 97: 240-8.
51. Westergren-Thorsson G, Antonsson P, Malmstrom A, Heinegård D, Oldberg A. The synthesis of a family of structurally related proteoglycans in fibroblasts is differently regulated by TGF-β. Matrix 1991; 11: 177-83.
52. Bassols A, Massagué K. Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 1988; 263: 3039-45.
53. Pearson CH, Winterbottom N, Fackre DS, Scott PG, Carpenter MR. The amino-terminal sequence of bovine skin proteodermatan sulphate. J Biol Chem 1983; 258: 15101-4.
54. Cöster L, Fransson LA. Isolation and characterisation of dermatan sulphate proteoglycans from bovine sclera. Biochem J 1981; 193: 143-53.